Employees Retirement System of Texas’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,410
Closed -$423K – 760
2021
Q1
$423K Hold
1,410
– – 0.01% 713
2020
Q4
$360K Hold
1,410
– – 0.01% 626
2020
Q3
$351K Hold
1,410
– – 0.01% 687
2020
Q2
$490K Sell
1,410
-16,791
-92% -$5.24M 0.01% 698
2020
Q1
$4.87M Buy
18,201
+1,791
+11% +$554K 0.09% 240
2019
Q4
$5.31M Hold
16,410
– – 0.08% 288
2019
Q3
$4.48M Buy
16,410
+8,810
+116% +$3.23M 0.07% 327
2019
Q2
$4.06M Sell
7,600
-1,133
-13% -$568K 0.06% 351
2019
Q1
$4.4M Buy
8,733
+6,800
+352% +$4.03M 0.07% 345
2018
Q4
$953K Buy
1,933
+1,200
+164% +$724K 0.02% 802
2018
Q3
$671K Buy
+733
New +$626K 0.01% 937
2018
Q2
– Sell
-1,467
Closed -$2.34M – 1089
2018
Q1
$2.34M Sell
1,467
-3,666
-71% -$4.72M 0.03% 576
2017
Q4
$4.6M Sell
5,133
-534
-9% -$316K 0.06% 399
2017
Q3
$2.04M Hold
5,667
– – 0.03% 630
2017
Q2
$1.66M Hold
5,667
– – 0.02% 688
2017
Q1
$2M Sell
5,667
-3,266
-37% -$734K 0.03% 642
2016
Q4
$1.64M Hold
8,933
– – 0.02% 690
2016
Q3
$2.3M Hold
8,933
– – 0.03% 562
2016
Q2
$1.91M Buy
8,933
+4,066
+84% +$909K 0.03% 594
2016
Q1
$1M Hold
4,867
– – 0.01% 749
2015
Q4
$1.23M Sell
4,867
-2,400
-33% -$494K 0.02% 695
2015
Q3
$1.2M Buy
+7,267
New +$1.29M 0.02% 719

Other funds holding NKTR

Employees Retirement System of Texas's NKTR Position: Q2 2021 in Review

Employees Retirement System of Texas sold out of Nektar Therapeutics (NKTR) in Q2 2021, closing a stake of 1,410 shares — an estimated $423K sold.

Employees Retirement System of Texas first reported a position in NKTR in Q3 2015 and held it in 22 quarters. The position peaked at $5.31M in Q4 2019. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2021.

  • Employees Retirement System of Texas reported no remaining Nektar Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Employees Retirement System of Texas sold 1,410 Nektar Therapeutics shares in Q2 2021, an estimated $423K.
  • Employees Retirement System of Texas first reported a position in Nektar Therapeutics in Q3 2015 and held it in 22 quarters.
  • Employees Retirement System of Texas's Nektar Therapeutics position peaked at $5.31M in Q4 2019.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2021.

Based on Employees Retirement System of Texas's 13F filing for Q2 2021, filed 10 Aug 2021.